Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Other Non-Cash Items 2011-2025 | ZTS

Zoetis annual/quarterly other non-cash items history and growth rate from 2011 to 2025. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
  • Zoetis other non-cash items for the quarter ending March 31, 2025 were $54M, a 700% decline year-over-year.
  • Zoetis other non-cash items for the twelve months ending March 31, 2025 were $-95M, a 86.27% increase year-over-year.
  • Zoetis annual other non-cash items for 2024 were $-0.119B, a 450% decline from 2023.
  • Zoetis annual other non-cash items for 2023 were $0.034B, a 2.86% decline from 2022.
  • Zoetis annual other non-cash items for 2022 were $0.035B, a 52.7% decline from 2021.
  
Zoetis Annual Other Non-Cash Items
(Millions of US $)
2024 $-119
2023 $34
2022 $35
2021 $74
2020 $134
2019 $34
2018 $-54
2017 $252
2016 $88
2015 $334
2014 $84
2013 $94
2012 $-33
2011 $161
2010 $-142
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $66.158B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.319B 28.63
Takeda Pharmaceutical (TAK) Japan $45.915B 9.13
Daiichi Sankyo, - (DSNKY) Japan $45.464B 23.30
BeOne Medicines - (ONC) Cayman Islands $32.283B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.049B 0.00
Summit Therapeutics (SMMT) United States $19.458B 0.00
Merck (MKKGY) Germany $16.692B 12.23
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.172B 11.65
Neurocrine Biosciences (NBIX) United States $13.065B 44.75
Orion OYJ (ORINY) Finland $10.973B 26.45
IPSEN (IPSEY) France $10.477B 0.00
Stevanato Group S.p.A (STVN) Italy $7.541B 46.11
Corcept Therapeutics (CORT) United States $7.514B 61.09
Madrigal Pharmaceuticals (MDGL) United States $7.419B 0.00
Grifols, S.A (GRFS) Spain $6.834B 0.00
Ionis Pharmaceuticals (IONS) United States $6.646B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.394B 0.00
Hypermarcas (HYPMY) Brazil $3.056B 20.10
Crinetics Pharmaceuticals (CRNX) United States $2.913B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.565B 8.99
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.498B 13.51
NewAmsterdam Pharma (NAMS) Netherlands $2.492B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.095B 0.00
Ocular Therapeutix (OCUL) United States $1.805B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.802B 0.00
ARS Pharmaceuticals (SPRY) United States $1.760B 0.00
Endo (NDOI) United States $1.606B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Harrow (HROW) United States $1.317B 0.00
Guardian Pharmacy Services (GRDN) United States $1.283B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Enliven Therapeutics (ELVN) United States $1.112B 0.00
Ardelyx (ARDX) United States $1.055B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.048B 0.00
Dyne Therapeutics (DYN) United States $1.025B 0.00
Akebia Therapeutics (AKBA) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $1.003B 5.41
Verve Therapeutics (VERV) United States $0.973B 0.00
ProKidney (PROK) United States $0.922B 0.00
Xeris Biopharma Holdings (XERS) United States $0.799B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
KalVista Pharmaceuticals (KALV) United States $0.769B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.743B 0.00
Zevra Therapeutics (ZVRA) United States $0.660B 0.00
Xencor (XNCR) United States $0.638B 0.00
Relay Therapeutics (RLAY) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.599B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Theravance Biopharma (TBPH) United States $0.563B 0.00
Organogenesis (ORGO) United States $0.554B 0.00
Oruka Therapeutics (ORKA) United States $0.544B 0.00
Bioventus (BVS) United States $0.514B 13.04
Tourmaline Bio (TRML) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Savara (SVRA) United States $0.391B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.336B 9.08
Altimmune (ALT) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
AleAnna (ANNA) United States $0.292B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.20
Nanobiotix S.A (NBTX) France $0.250B 0.00
OmniAb (OABI) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.206B 0.00
4D Molecular Therapeutics (FDMT) United States $0.195B 0.00
China SXT Pharmaceuticals (SXTC) China $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Liminatus Pharma (LIMN) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.138B 0.00
Lyell Immunopharma (LYEL) United States $0.137B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.111B 18.20
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Context Therapeutics (CNTX) United States $0.080B 0.00
Dominari Holdings (DOMH) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Metagenomi (MGX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Rafael Holdings (RFL) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Avalo Therapeutics (AVTX) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Inotiv (NOTV) United States $0.060B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 35.78
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
FibroGen (FGEN) United States $0.031B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Incannex Healthcare (IXHL) Australia $0.018B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
BioVie (BIVI) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.43
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00